Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-19The Effect of Metformin Treatment on Cognitive Impairment in Individuals With Schizophrenia: A 24-week Multicentre Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-19Autobiographical Memory Organization in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-12-18A Randomized, Open-Label, Single-Dose, Two-Period, Crossover Phase I Clinical Study to Evaluate the Food Effect on the Pharmacokinetics of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-12-17Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-12-17Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-16Feeling of Being in Control of One's Own Action: Which Mechanisms in Healthy Volunteers and in Mental Diseases
-
CLINICAL_TRIALS study record update · 2025-12-16Effectiveness of a Joint Crisis Plan (SOS Plan) in Preventing Relapses in Patients Diagnosed With Schizophrenia and Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2025-12-15State Representation in Early Psychosis - Project 4
-
CLINICAL_TRIALS study record update · 2025-12-12Cognitive Remediation in Forensic Mental Health Care
-
CLINICAL_TRIALS study record update · 2025-12-12A Phase III Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Examine the Efficacy and Safety of Iclepertin Once Daily Over 26 Week Treatment Period in Patients With Schizophrenia (CONNEX-2)
-
CLINICAL_TRIALS study record update · 2025-12-10Proof of Mechanism Study Using a Retinal Biomarker to Predict Treatment Response With Intravenous Sodium Nitroprusside in Symptomatic Early Course Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-12-10Effectiveness of Metacognitive Training on Symptoms and Cognitive Biases in Taiwanese Individuals With Mental Disorders: A One-Group Pretest-Posttest Study
-
CLINICAL_TRIALS study record update · 2025-12-09Rôle Des Colliculi inférieurs Dans Les Hallucinations Auditives : étude Pilote Par Neuroimagerie
-
CLINICAL_TRIALS study record update · 2025-12-09Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
-
CLINICAL_TRIALS study record update · 2025-12-08Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study
-
CLINICAL_TRIALS study record update · 2025-12-05Risperidone ISM® Effectiveness in Schizophrenia Patients Hospitalised Due to A Relapse: a Prospective Non-interventional Evaluation (RESHAPE Study)
-
CLINICAL_TRIALS study record update · 2025-12-05An Open Label, Randomized, Two-period, Twotreatment, Two-sequence, Truncated, Crossover, Balanced, Single Dose Oral Bioequivalence Study.
-
CLINICAL_TRIALS study record update · 2025-12-05Effectiveness of Navigated Transcranial Magnetic Stimulation (nTMS) of Left Supramarginal Gyrus for Negative Symptoms : A Double-blind, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-05A Multicenter, Randomized, Open-Label, Parallel-Group, Multiple-Dose Bioequivalence Study of Paliperidone Palmitate Injection in Chinese Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-12-04Imagery Rescripting for Early Psychosis: a Multiple-Baseline Single-Case Experimental Design.
-
CLINICAL_TRIALS study record update · 2025-12-02Feasibility and Acceptability of Mobile Mental Health Application for the Improvement of Medication Adherence in Persons With Schizophrenia(SZ) and Schizoaffective Disorder(SZA)
-
CLINICAL_TRIALS study record update · 2025-12-02A Pilot Study to Assess the Effect of Prucalopride on Cognitive Functioning in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-11-25A Randomized Controlled Trial to Evaluate Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-11-24Implementing mHealth for Schizophrenia in Community Mental Health Settings
-
CLINICAL_TRIALS study record update · 2025-11-21A Phase 3, Multicenter, Two-part Study With a 5-week Double-blind Part (Randomized, Parallel-group, Placebo-controlled) Followed by a 12-week Open-label Extension Part, to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia